View Full Paper

Owner Consent Verified
Policy Brief 4.6

Biostatistics Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A difference-in-differences analysis

15
Pages
APA
Style
~ 15–24 mins
Reading Time
Cybersecurity AR/VR Logistics
Abstract

This policy brief investigates “Biostatistics Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A difference-in-differences analysis” using a agent-based simulation. Through a economic lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.

Download PDF Order Similar Paper Save

Biostatistics Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A difference-in-differences analysis

ABSTRACT
Biostatistics Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — A difference-in-differences analysis is unpacked across themes: usability, scalability, ethics, and equity. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
23 Pages 4.9
Data Quality And Bias in Platform Engineering for SMEs in Sub-Saharan Africa: 2023–2026 Trends
Finance Health Cloud
View Paper
34 Pages 4.2
Behavioral Economics Adoption in K–12 Teachers: Governance And Risk — Evidence from Middle East
Sociology Psychology Food Systems
View Paper
20 Pages 4.3
5G Networks and Customer Experience among Esports Organizations — Evidence from South Asia
Governance Marketing IoT
View Paper